Keyword: United Kingdom

In roundworm models of Parkinson's, probiotic Bacillus subtilis lowered the buildup of alpha-synuclein in the brain—a culprit in the disease.

As the U.K. prepares to leave the EU, newly elected Prime Minister Boris Johnson has sketched out plans that aim to speed up trials.

Oxford, U.K.-based clinical trial artificial intelligence tech company Sensyne Health has signed a new research project deal with Swiss major Roch

The new parliamentary arithmetic gives Boris Johnson the numbers to pass the withdrawal agreement and take the U.K. out of the EU.

The spending plan will amount to an extra £83 million ($107 million) a year.

The U.K. is currently a leading European location for clinical trials but that position could be threatened by Brexit and other factors.

University of Bristol researchers are developing a device that mimics a dog's sense of smell to detect the chemical signatures of certain diseases.

Eli Lilly is closing down its U.K.-based Erl Wood neuroscience in Surrey, leading to cuts and relocations.

A drug that causes cancer cells to divide too rapidly and die was effective when combined with chemo in mouse models of triple-negative breast cancer.

The VC plans to pump $150 million into biotechs that are working to extend use of advanced therapies to major diseases such as diabetes.